TY  - JOUR
AU  - Hernandez-Martinez, Alvaro
AU  - Navajas-Hernandez, Pilar
AU  - Martin-Rodriguez, Maria Del Mar
AU  - Lazaro-Saez, Marta
AU  - Olmedo-Martin, Raul
AU  - Nuñez-Ortiz, Andrea
AU  - Argüelles-Arias, Federico
AU  - Fernandez Cano, Maria Carmen
AU  - Gallardo-Sanchez, Francisco
AU  - Marin-Pedrosa, Sandra
AU  - Gonzalez-Garcia, Javier
AU  - Vazquez-Moron, Juan Maria
PY  - 2021
DO  - 10.17235/reed.2022.8380/2021
SN  - 1130-0108
UR  - http://hdl.handle.net/10668/21721
T2  - Revista espanola de enfermedades digestivas
AB  - Tofacitinib is a Janus kinase inhibitor approved for the treatment of moderate-severe ulcerative colitis (UC). This study aimed to evaluate its efficacy in a real-life setting. a retrospective and multicenter observational study was performed with UC...
LA  - en
PB  - Sociedad Espanola de Patologia Digestiva
KW  - Área de Gestión Sanitaria Norte de Almería
KW  - Tofacitinib
KW  - Ulcerative colitis
KW  - Real-life
KW  - Colitis, Ulcerative
KW  - Humans
KW  - Piperidines
KW  - Pyrimidines
KW  - Retrospective Studies
TI  - Efficacy and safety of tofacitinib in the treatment of ulcerative colitis: real-life experience in Andalusia.
TY  - research article
VL  - 114
ER  -